期刊文献+

血浆中CD63水平的变化在2型糖尿病中的临床意义 被引量:2

Change of plasma CD63 level in patients with T2DM and its clinical significance
下载PDF
导出
摘要 目的:研究血浆中CD63水平的变化在2型糖尿病中的临床意义。方法:采用流式细胞仪分别检测54名健康人(NC组),55例2型糖尿病患者(T2DM组)的血浆血小板活化标志物(CD63)水平。结果:2型糖尿病患者血小板因子CD63异常升高,NC组与T2DM组的血浆血小板活化标志物CD63水平相比,有显著性差异(P<0.01)。结论:血小板因子CD63的检测可以作为2型糖尿病患者早期诊断和病情监测的一个临床指标。 Objective:To study the level of CD63 in plasma in patients with T2DM and its clinical significance.Methods:Level of CD63 in plasma was detected by flowcytometer in 55 patients with T2DM(T2DM group)and 54 healthy Subjects(NC group).Results:Level of CD63 in plasma in T2DM group(13.53±0.66)was significantly higher than that in NC group(8.49±0.27)(P0.01).Conclusion:Level of CD63 in plasma in patients with T2DM is significantly higher than that in normal control group.So the level of CD63 in plasma can be a clinical sign for T2DM patients to early discovery and condition monitor.
出处 《河南大学学报(医学版)》 CAS 2011年第1期58-59,共2页 Journal of Henan University:Medical Science
基金 河南省科技攻关基金资助项目(0424410102)
关键词 2型糖尿病 血小板因子 CD63 T2DM Platelet factor CD63
  • 相关文献

参考文献5

  • 1Sedirnayr P, Grobhaulot B, Muntean W, et al. Flow eytometric detection of intracellular platelet antigen[J]. Cytomtry,1996,23(8) :284.
  • 2Bacwer H B. New features of the national cholesterol education program adult treatment panelⅢ lipid lowering guidelines[J]. Clineardiol, 2003,26 : 19 -24.
  • 3Lee H,Chan J L,Yiannakouris N,et al. Circulating resis tin levels are not associated with obesity or insulin resistance in human and not regulated by fasting or leptin adminislration: cross-seetional and intervenlional studies in normal insulin resislant and diabetic subjects[J]. J C Lin Endocrinology Metab,2003,88(10):4 848-4 856.
  • 4陆益龙,于焱,金蓉珍,陆德澄,孙晓春,朱伟,焦志军,许文荣.高血脂对老年冠心病患者血小板活化因子水平影响[J].实用老年医学,1999,13(5):265-265. 被引量:8
  • 5Zimmcrman G A,Prescott S M,Mcintgre T M,et al. En dothelial cell interactions wltln granulocytes: tetlnerlng anti singaling moleeules [J]. lmmunel Today, 1992, 13 ( 3 ) : 93-99.

共引文献7

同被引文献18

  • 1邹丽伟.糖尿病患者颈动脉粥样硬化的超声检测[J].中国超声诊断杂志,2005,6(7):525-525. 被引量:11
  • 2Cmager MA,Luscher TF,Cozentino F,et al.Diabetes and vascular disease:pathophysiology,clinical consequences,and medical therapy:part I[J].Circulation,2003,108:1527-1532.
  • 3Dunn EJ,Grant PJ.Type 2diabes:an atherothrombotic Syndrome[J].Curry Mol Med,2005,5:323-332.
  • 4Amos AF,MeCarty DJ,Zimmet P.The rising global burden of diabetes and its complications:estimates and projections to the year 2010[J].Diabet Med,1997,14(5):1-85.
  • 5Yokoyama H,Katakami N,Yamasaki Y.Recent advances of intervention to inhibit progression of carotid intimamedia thickness in patients with type 2diabetes mellitus[J].Stroke,2006,37(9):2420-2427.
  • 6Scheinowitz M,Pakala R,Ben-Dor I,et al.Platelet reactivity in diabetic patients subjected to acute exercise stress test[J].Cardiovasc Revasc Med,2011,12(1):20-24.
  • 7Psaila B,Bussel JB,Linden MD,et al.In vivo effects of eltrombopag on platelet function in immune thrombocytopenia:no evidence of platelet activation[J].Blood,2012,26,119(17):4066-4072.
  • 8Nurden AT. Platelets, inflammation and tissue regeneration [J].Thromb Haemost,2011,105(Suppl 1) :S13--33.
  • 9Derosa G,Maffioli P.Efficacy and safety profile evaluation of acarbose alone andin association with other antidiabetic drugs : a systematic review[J].Clin Ther, 2012,34 (6) : 1221 -- 1236.
  • 10朱在卿,许贵刚,刘洋,郭艳丽.急性脑梗死患者血小板CD62P和CD63的表达及意义[J].山东医药,2011,51(41):49-50. 被引量:7

引证文献2

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部